Selective Serotonin Reuptake Inhibitor-Treatment Does Not Show Beneficial Effects on Cognition or Amyloid Burden in Cognitively Impaired and Cognitively Normal Subjects

Preclinical studies indicate that selective serotonin reuptake inhibitors (SSRI) have beneficial effects on Alzheimer-related pathologies. Therefore, the aim of this study was to evaluate the influence of SSRI-treatment on amyloid burden in (18)F-Florbetapir-positron emission tomography (PET) and on...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouter, Yvonne, Bouter, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260503/
https://www.ncbi.nlm.nih.gov/pubmed/35813957
http://dx.doi.org/10.3389/fnagi.2022.883256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260503/
https://www.ncbi.nlm.nih.gov/pubmed/35813957
http://dx.doi.org/10.3389/fnagi.2022.883256

Ejemplares similares